Accuri Reels in $4M in New Investments | GenomeWeb

NEW YORK (GenomeWeb News) – Flow cytometry systems maker Accuri Cytometers has received $4 million in Series D financing from current and new investors, the company said today.

The Ann Arbor, Mich.-based firm said it plans to use the funds support manufacturing and marketing of its C6 Flow Cytometer and the CSampler, which is used to automate the C6.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.